Articles from T3Bioscience

Novel Antimicrobial Compound Expands IP Portfolio
T3Bioscience (T3), the US-based company built upon powerful and novel microbial technology for managing agricultural bacterial and fungal pathogens, announced an expansion to its IP portfolio. Taiwan has issued the company's first patent outside the United States for the startup's initial product, RejuAgro, a nature-derived antimicrobial solution poised to help farmers manage debilitating crop pathogens while also combating abiotic resistance.
By T3Bioscience · Via Business Wire · June 10, 2026